Moroni, Mauro.
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Mauro Moroni
Moroni, Mauro <1938-2015>
Moroni, Mauro (Professor of communicable diseases)
Moroni, Mauro 1938-
VIAF ID: 166155309 (Personal)
Permalink: http://viaf.org/viaf/166155309
Preferred Forms
-
100 0 _
‡a
Mauro Moroni
-
200 _ 1
‡a
Moroni
‡b
, Mauro
‡f
<1938-2015>
-
200 _ |
‡a
Moroni
‡b
Mauro
-
100 1 _
‡a
Moroni, Mauro
-
100 1 _
‡a
Moroni, Mauro
‡c
(Professor of communicable diseases)
-
100 1 _
‡a
Moroni, Mauro
‡d
1938-
-
100 1 _ ‡a Moroni, Mauro.
4xx's: Alternate Name Forms (2)
Works
| Title | Sources |
|---|---|
| AIDS, dalla paura alla speranza |
|
| Epidemiology of non-A, non-B hepatitis |
|
| Incidence of adipose tissue alterations in first-line antiretroviral therapy: the LipoICoNa Study |
|
| Infezioni opportunistiche HIV-correlate : terapia e profilassi / Mauro Moroni, Spinello Antinori |
|
| Interleukin-2 immunotherapy exerts a differential effect on CD4 and CD8 T cell dynamics. |
|
| Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011 |
|
| Low-dose prolonged intermittent interleukin-2 adjuvant therapy: results of a randomized trial among human immunodeficiency virus-positive patients with advanced immune impairment. |
|
| Low Frequency of Severe Hepatotoxicity and Association With HCV Coinfection in HIV-Positive Patients Treated With HAART |
|
| Malattie a trasmissione sessuale |
|
| Malattie infettive / Mauro Moroni, Roberto Esposito |
|
| Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy |
|
| Virologic and immunologic response to regimens containing nevirapine or efavirenz in combination with 2 nucleoside analogues in the Italian Cohort Naive Antiretrovirals (I.Co.N.A.) study |
|
